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Bikunin, which is an inhibitor of serine proteases, is
widely distributed in human tissues, including liver,
kidney, and mucous membranes of the stomach and
colon. The aim of this study was to clarify whether
bikunin is expressed in human epidermis and its
appendages. Immunoblot analysis using a specific
polyclonal antibody to bikunin revealed that a single
43 kDa protein is present in the cell lysate from the
human keratinocyte cell line HaCaT. Immunohisto-
chemically, dotted reaction products stained with anti-
bikunin antibody were localized on the cell boundary
in both basal and spinous cell layers, except on the cell
boundary of the basal cells facing the basal membrane.
There were no reaction products in the granular-horny
cell layers. Reaction products stained with anti-bikunin
antibody were also observed on the hair bulb cells and
Bikunin, which is an inhibitor of serine proteases(Gebhard and Hochstrasser, 1986), also termed ulinas-tatin (Kato et al, 1995) and urinary trypsin inhibitor(UTI) (Sumi et al, 1977; Tanaka et al, 1982), was firstreported by Shulman (1955) in the 1950s. Bikunin is
first synthesized as a precursor polypeptide, which consists of
bikunin and α1-microglobulin (Salier et al, 1996), and is cleaved
after the completion of the chondroitin sulfate chain (Sjoberg et al,
1995). The bikunin polypeptide has two Kunitz domains, and each
domain inhibits different proteases (Hochstrasser et al, 1981).
Domain I, located in the N-terminal, inhibits chymotrypsin and
leukocyte elastase, and domain II, located in the C-terminal inhibits
plasmin, trypsin, and chymotrypsin (Hochstrasser et al, 1981).
In some malignant diseases, the level of bikunin is significantly
increased (Yamamoto et al, 1986; Nishio et al, 1989; Yoshida et al,
1989). Bikunin binds to the tumor cell surface and inhibits the
proteolytic enzyme plasmin, thus specifically reducing invasion and
metastasis of tumor cells (Kobayashi et al, 1994a, b, c, d, 1996).
Although the expression of the mRNA of bikunin was shown
to be derived from the α1-microglobulin/bikunin gene (Salier et al,
1996) and bikunin mRNA expression was reported only in the
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eccrine sweat gland cells, but not on apocrine sweat
glands. Also, reaction products were observed on the
luminal surface of the renal proximal tubules and
in the cytoplasm of these cells. In immunoelectron
microscopy, gold particles were observed on the cell
membranes close to the desmosomal structures.
Reverse transcription–polymerase chain reaction and
northern blot analyses showed that mRNA specific for
bikunin was expressed in HaCaT cells and human
epidermal keratinocytes obtained from suction blisters,
and was contained in a commercially available human
keratinocyte cDNA preparation. These findings indi-
cate that bikunin is expressed in keratinocytes and
may play an important part in regulating keratinocytes
in either mitosis or inflammation. Key words: bikunin/
HC-human/HI-30. J Invest Dermatol 113:182–188, 1999
liver (Kaumeyer et al, 1986; Salier et al, 1987), immunohistochemical
staining revealed that this inhibitor is widely distributed in body
tissues such as the brain, lung, liver, stomach, and kidney, and in
body fluids (Kaumeyer et al, 1986; Salier et al, 1987; Nishio
et al, 1989).
Recently, Itoh et al (1996) reported expression of mRNA of
bikunin in the human pancreas, suggesting that bikunin may be
expressed in tissues other than the liver; however, there has been
no evidence showing the presence of bikunin in human skin
(Yoshida et al, 1989).
In human epidermis, keratinocytes are bound to each other
by desmosomes, the adhesion and dissociation of which occurs
repeatedly during mitosis and differentiation (Wolf and
Wolf-Schreiner, 1976; Jones et al, 1986; Kitajima et al, 1986, 1987;
Koch et al, 1990; Buxton et al, 1993). Although it is considered
that desmosomes are digested by proteases like plasmin during
keratinocyte dissociation (Hennings et al, 1980, 1983; Boyce and
Ham, 1983), the mechanisms of inhibition of plasmin or other
proteases are not completely understood and the mechanisms of
dissociation under normal conditions have not been completely
clarified yet.
In this study, we used reduced bikunin as the immunizing
antigen, and succeeded in producing specific antibody. Using this
antibody, we demonstrated that bikunin is expressed on the
keratinocyte cell membrane in normal human skin, mainly in
epidermis, hair follicles, and eccrine sweat glands.
MATERIALS AND METHODS
Polyclonal antibody production The antibody was obtained by injec-
tion of 0.5 mg of bikunin (the purified bikunin was kindly provided by
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Mochida Pharmaceutical Corp.), which had been previously reduced by
2-mercaptoethanol, with 0.5 ml of Freund complete adjuvant into the
subcutaneous tissue of two rabbits. The immunization was repeated six
times within 2 mo, and then the anti-serum was obtained. The anti-serum
was further purified using a bikunin affinity column which was prepared
as follows: 10 mg of purified bikunin was dissolved in 1 ml of 0.2 M
NaHCO3 buffer containing 0.5 M NaCl, pH 8.3, and gently added to a
1 ml volume Hitrap affinity column (Pharmacia, Tokyo, Japan). After
washing according to the manufacturer’s recommendations, bikunin was
fixed to the column with 0.5 M ethanolamine containing 0.5 M NaCl,
pH 8.3, washed with a 0.1 M acetic acid solution containing 0.5 M NaCl,
pH 4.0, and equilibrated with 0.05 M phosphate buffer containing 0.1%
NaN3, 0.5 M NaCl, pH 7.4, at 4°C. The anti-serum, which had been
previously equilibrated with 0.05 M phosphate buffer containing 0.5 M
NaCl, pH 8.3, by PD-10 column chromatography, was gently added to
the bikunin affinity column, and then eluted with 0.2 M glycine–HCl
buffer containing 0.5 M NaCl, pH 2.5. The eluate was immediately
neutralized with 2 M Tris–HCl, pH 8.5, and then the buffer was changed
to phosphate-buffered saline by PD-10 column chromatography. Thus
purified anti-bikunin antibody (Ig G fraction) was used for further
experiments.
The specificity of the anti-bikunin antibody for the purified, human
bikunin was confirmed by immunoblot analysis.
Immunoblot analysis The epidermis obtained from suction blisters,
HaCaT cells, and human serum was examined by immunoblot analysis.
HaCaT cells were cultured in the following conditions: (i) normal culture
medium; (ii) in normal medium and then cultured in serum-free medium
for an additional 48 h before becoming confluent; (iii) at a low calcium
concentration, then at a high calcium concentration; and (iv) low calcium
concentration and harvested. Both the epidermis obtained from suction
blisters and HaCaT cells were washed in phosphate-buffered saline three
times to remove the serum components, and the epidermis was homogen-
ized in RIPA buffer [phosphate-buffered saline containing 1% NP-40,
0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), and 0.234
trypsin inhibitor unit aprotinin per ml] and stirred for 1 h at room
temperature, and HaCaT cells were extracted by vortexing in RIPA buffer,
and both were finally centrifuged at 15,000 3 g for 30 min. The cell
lysates, the culture supernatants, concentrated 100 times, and human serum
were then subjected to SDS–polyacrylamide gel electrophoresis, transferred
on to Immobilon (Millipore, Bedford, MA) membranes, and allowed to
react with anti-bikunin antibody diluted 1:500 for 16 h at 4°C. The
reaction products were further allowed to react with anti-rabbit IgG goat
IgG labeled with peroxidase for 90 min at room temperature, and finally
visualized by diaminobenzidine and H2O2.
Immunohistochemistry Either the indirect immunofluorescence
method (fluorescein isothiocyanate method) or labeled streptavidin–biotin
method (Gueston et al, 1979) was used to examine the localization of the
antigen in the epidermis. Each of more than six samples of paraffin-
embedded sections from normal human epidermis, oral mucosa, tongue
and scalp skin, and paraffin-embedded sections from needle biopsies of the
kidney were deparaffinized and treated for 10 min at 37°C in phosphate-
buffered saline containing 0.1% trypsin before immunostaining, and were
further incubated with either our anti-bikunin antibody diluted 1:500 or the
anti-serums produced by Yoshida et al (1989), or Mochida Pharmaceutical,
diluted 1:500 for 1 h at 37°C.
Immunoelectron microscopy Normal human forearm skin obtained
from a surgical operation for a benign skin tumor was minced into 1 mm
cubes and immediately fixed in 4% paraformaldehyde in 0.1 M phosphate
buffer, pH 7.4, at 4°C for 1 h without glutaraldehyde, then rinsed
thoroughly in 0.1 M phosphate buffer, pH 7.4, and embedded in Unicryl
K4M resin (BioCell, Cardiff, U.K.) after dehydration, and used to prepare
ultrathin sections, which were incubated with the purified, anti-bikunin
antibody diluted 1:500 at 37°C for 1 h. After being rinsed, they were
further incubated with anti-rabbit IgG goat IgG labeled with 15 nm gold
particles, diluted 1:100 (Amersham Japan, Tokyo), at 37°C for 30 min.
Finally, after being stained with uranyl acetate and lead acetate, these
ultrathin sections were observed using an HU-7100 electron microscope
(Hitachi, Tokyo, Japan).
RNA extraction Total RNA was isolated from the human keratinocyte
cell line HaCaT (Boukamp et al, 1988) and epidermis from suction blisters
according to standard procedures (Luduena et al, 1992). Briefly, the cells
or the epidermal sheet were lysed in 4 M guanidine isothiocyanate,
3 M sodium acetate (pH 4.8), 1% lauroylsarcosin, and 100 mM 2-
mercaptoethanol for 10 min, mixed for 1 min by vortexing, and frozen
at –20°C until use. Cell lysates were extracted twice with acidic phenol
(pH 4.8) and chloroform (5:1 vol/vol). Precipitation was performed with
2.5 volumes of cold ethanol and one-third volume of 3 M sodium acetate
buffer, pH 4.7, at –20°C overnight. The pellet was rinsed with 70%
ethanol, evaporated in a vacuum desiccator and dissolved in doubly distilled
water. The amounts of RNA in samples were determined photometrically
at 260 nm and the RNA was then used for reverse transcription–polymerase
chain reaction (reverse transcription–PCR).
Reverse transcription–PCR Five micrograms of total RNA was
reverse-transcribed. Reaction buffer (5 3 250 mM Tris–HCl, pH 8.3,
250 mM KCl, 25 mM MgCl2) and 4 µl of 25 mM dNTP (each), 1 µl of
RNase inhibitor (Promega, WI) or and 0.8 µl of dT17 (Takara, Tokyo,
Japan) were mixed and diluted to 38 µl with RNase-free water, heated to
65°C for 5 min in a water bath, and chilled on ice. After the addition of
2 µl of MuLV reverse transcriptase (Promega), samples were incubated at
37°C for 90 min and the cDNA was then precipitated with 2.5 volumes
of cold ethanol and one-third volume of 3 M sodium acetate buffer,
pH 7.8, at –20°C overnight. The pellet was rinsed with 70% ethanol,
evaporated in a vacuum desiccator and dissolved in doubly distilled water.
To perform PCR amplification on a semiquantitative basis, we amplified
all cDNA samples with primers specific for β-actin using various cycle
numbers and dilution factors, and thereby determined the optimal concen-
tration of each sample and a cycle number showing a logarithmic increase
in amplification. Samples were then amplified using primers specific for
CD95. For PCR amplification, we used a 50 µl reaction mixture containing
1 µl cDNA, 200 µM dNTP (each), and 20 pmol of each primer pair. The
PCR primers for bikunin were as follows: sense primer: 59-TGGGCAACT-
GGTAACT GAAG-39; anti-sense primer: 59-GCAGCTCCTCATCAC-
CATCA-39. These primers correspond to exon 7 and the junction between
exons 9 and 10 (from 7020 to 7038 in exon 7 and from 8802 in exon 9–
9471 in exon 10; Yetr and Gebhard, 1990). The PCR primers for β-actin
were as follows: sense primer: 59-CACCTTCTACAATGAGCTGC-
39; anti-sense: 59-TTCATGAGGTAGTCCGTCAG-39. Positive controls
(human liver cDNA and human keratinocyte cDNA) (Clontech, CA) and
a negative control (without cDNA) were included in each experiment.
Northern blot analysis For northern blot analysis (Aragane et al, 1994),
total cellular RNA was denatured in 50% formamide, 6% formaldehyde,
1 3 0.02 M 3-[N-morpholino] propane-sulfonic acid (MOPS), 0.05 M
sodium acetate (pH 7.0), and 0.01 M Na2 ethylenediamine tetraacetic acid
at 65°C for 5 min. Ten micrograms of total RNA was separated by gel
electrophoresis using 1% agarose gels containing 6.3% formaldehyde and
1 3 MOPS. Gels were run at 100 V for 1 h. To monitor equal loading
of RNA samples, membranes were stained with 1 3 MOPS solution
containing 0.05 µg per ml ethidium bromide and ribosomal RNA was
photographed under an ultraviolet lamp. Subsequently, RNA samples were
transferred to a nylon filter by capillary blotting. Filters were baked at
80°C for 2 h. After prehybridization at 42°C in 50% formamide, 10%
dextran sulfate, 1% SDS, and 1 M MaCl for at least 15 min. Hybridization
was conducted using deoxyadenosine-59-[32P]triphosphate-labeled cDNA
probes encoding bikunin which was obtained by PCR amplification of
cDNA derived from human normal keratinocytes and their sequences were
ascertained as 100% identical to established sequences of bikunin as listed
in GenBank by a sequencing analysis. The labeled probe and heat-denatured
salmon sperm DNA (100 µg per ml) were added to the prehybridization
solution and incubated at 42°C at least 12 h in a water bath. After
hybridization, filters were washed in 2 3 sodium citrate/chloride buffer
at room temperature for 10 min, 2 3 sodium citrate/chloride buffer
containing 1% SDS at 60°C for 1 h, and 0.1 3 sodium citrate/chloride
buffer for 1 h at room temperature. Filters were exposed to X-ray films
at –70°C.
RESULTS
The 43 kDa, 36 kDa, and 19 kDa epidermal proteins cross-
reacted with the anti-bikunin antibody Cell lysates were
prepared from normal human keratinocytes obtained from suction
blister epidermis and cultured HaCaT cells. HaCaT cells were
cultured in various conditions which were described in Materials
and Methods. The culture supernatants were collected and concen-
trated 100-fold before use. Cell lysates, culture supernatants, and
normal human serum were subjected to SDS–polyacrylamide gel
electrophoresis, blotted on to Immobilon membranes, and reacted
with the purified anti-bikunin antibody. The purified anti-bikunin
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Figure 1. Anti-bikunin antibody reacted with the 43 kDa, 36 kDa,
and 19 kDa kEratinocyte proteins in immunoblotting analysis.
Human serum (A, lane b) and bikunin (A, lane a) were subjected to SDS–
polyacrylamide gel electrophoresis, transferred to Immobilon membranes,
and reacted with anti-bikunin antibody (1:500). Human inter-α-trypsin
inhibitor (225 kDa) and pre-α-inhibitor (125 kDa) indicated by an
arrowhead. In the cell lysate of suction blister epidermis (B, lanes a–c), the
43 kDa, 36 kDa, and 19 kDa polypeptides were reacted with anti-bikunin
antibody (lane b, indicated by an arrowhead). A keratinocyte cell line, HaCaT
(C, lanes b–i and k–r), was cultured under normal culture conditions for
3 d (lanes b and k), HaCaT cells were first cultured in normal medium,
and then cultured for an additional 48 h in serum-free medium (lanes c
and l), HaCaT cells were cultured at a low calcium concentration, and
changed to a high-calcium medium (lanes d and m), or HaCaT cells were
cultured at a low calcium concentration (lanes e and n). Lanes b–e and k–n
in C: the cell lysates, and lanes f–i and o–r in C: the culture supernatants,
concentrated 100 times. An immunoreactive, 43 kDa band was detected
only in lanes k–n. (A) Lanes a and b, (B) lanes a and b, and (C) lanes j–r are
the immunoblot analysis with anti-bikunin antibody, and (B) lane a is with
preimmune serum. (B) Lanes c and m, and (C) lanes a–i are Fast Green
stain. a in A, and a and j in C: purified bikunin, m: molecular markers
[from top; bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic
anhydrase (30 kDa), soybean trypsin inhibitor (20.1 kDa) and lactoalbumin
(14.4 kDa)]. Arrowhead in A: serum inter-α-trypsin inhibitor and pre-
α-inhibitor.
antibody specifically recognized antigenic bikunin (Fig 1A, lane
a), serum inter-α-trypsin inhibitor (225 kDa) and pre-α inhibitor
(125 kDa) in human serum (Fig 1A, lane b). This antibody also
reacted with 43 kDa, 36 kDa, and 19 kDa epidermal proteins of
human, normal epidermis (Fig 1B, lane b), and with a 43 kDa
protein in all cell lysates of cultured HaCaT cells (Fig 1C, lanes
k–n); however, no 43 kDa protein was detected in the culture
supernatants (Fig 1C, lanes o–r). Purified bikunin showed a broad
band in the immunoblots ranging from 30 kDa to 45 kDa, which
was in good agreement with the previous reports of other researchers
(Balduyck et al, 1986; Laroui et al, 1988; Itoh et al, 1996; Kobayashi
et al, 1994b, c, 1996).
Figure 2. Anti-bikunin antibody reacted with the CB of normal
human epidermis and the renal proximal tubular cells. Paraffin-
embedded sections of normal human skin and kidney were pretreated with
0.1% trypsin and reacted with anti-bikunin antibody. Dotted fluorescence
was observed on the cell membrane of epithelial cells and dermal capillary
endothelial cells, and the positive reaction products were seen on the inner
surface of the proximal renal tubules and in the cytoplasm of the same
tubular cells. (A) Normal human skin reacted with anti-bikunin antibody.
White dots indicate the outer surface of the stratum corneum. (B) Normal
oral mucosa reacted with anti-bikunin antibody. (C) The proximal renal
tubular cells reacted with anti-bikunin antibody. g: glomerulus. Scale
bar: 40 µm.
Epidermal bikunin is located on the boundary of baso-
squamous cells and of hair follicle cells In immunohisto-
chemical staining, dotted reaction products were observed on the
cell boundary (CB) of keratinocytes from basal cells to the upper
spinous cells, except for the cell membrane facing the basal
membrane (Fig 2A), and on the CB of oral mucosa (Fig 2B), but
there were no reaction products in the granular-horny cell layers
(Fig 2A). There was also positive staining on the endothelial cells
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Figure 3. Bikunin is located on the membrane of eccrine sweat
gland cells but not on apocrine sweat gland cells. Paraffin-embedded
sections of normal human scalp skin were pretreated with 0.1% trypsin
and reacted with anti-bikunin antibody. Fluorescence was observed on the
cell membrane of the eccrine sweat gland cells and some dermal cells. A,
eccrine sweat gland; B, apocrine sweat gland; x, luminal area of sweat
gland. Scale bar: 40 µm.
of capillaries in the dermis (Fig 2A). This purified, anti-bikunin
antibody as well as the antibody from Mochida Pharmaceutical
reacted with the luminal surface and intracytoplasmic materials of
renal proximal tubules (Fig 2C). In addition, the antibody provided
by Mochida Pharmaceutical also reacted with the epidermis. Dotted
reaction products were observed on the membrane of eccrine sweat
ducts and the secretory portion (Fig 3A), but there was no positive
reaction in apocrine sweat glands (Fig 3B). There were also dotted
reaction products on the cell membrane of the outermost cells of
the outer root sheath at the level of the hair supra-bulge region
(Fig 4A), and at the level of the hair supra-bulbar region (Fig 4B),
and on hair bulb cells (Fig 4C). In immunoelectron microscopy,
the gold particles appeared to be located on the cell membrane
close to desmosomes (Fig 5).
The mRNA of bikunin is expressed in keratinocytes In
order to examine whether mRNA specific for bikunin is expressed
in human epidermal keratinocytes, we performed semiquantitative
reverse transcription–PCR using primers specific for bikunin and
northern blot analysis. Reverse transcribed cDNA samples derived
from a human keratinocyte-derived cell line, HaCaT, epidermal
cells of suction blister samples, and neonatal foreskin-derived
cultured human keratinocytes were amplified with primer pairs
specific either for bikunin or for β-actin. As a positive control,
cDNA derived from human liver and keratinocytes were also
amplified, as it is known that human liver cells express bikunin
mRNA (Kaumeyer et al, 1986; Salier et al, 1987). As expected, the
sample derived from human liver gave rise to a specific signal for
bikunin (Fig 6, lane 4) and the sample from human keratinocytes
also showed a specific signal for bikunin (data not shown). Further-
more, PCR amplification revealed the presence of the bikunin
transcript in the human keratinocyte-derived cell line HaCaT (lane
1), in samples obtained from suction blisters (lane 2), and in cultured
human normal keratinocytes (lane 3). The specificity of PCR
products for bikunin was determined by sequencing analyses of
PCR products amplified from cDNA derived from normal human
keratinocytes (data not shown). To quantitate the amount of
bikunin-specific transcript in keratinocytes, we amplified serially
diluted cDNA derived from human liver in parallel with samples
of HaCaT and of suction blister specimens, respectively, and
Figure 4. Bikunin is located on outer root sheath cells and hair
bulb cells. Paraffin-embedded sections of normal human scalp skin were
pretreated with 0.1% trypsin and reacted with anti-bikunin antibody. (A)
Positive reaction was observed on the outer root sheath cell membranes
at the level of the hair supra-bulge region. (B) Positive reaction was
observed on the outer root sheath cells at the level of the hair supra-bulbar
region. (C) Positive reaction was observed on the hair bulb cells. Some
dermal cells are also positively stained, as shown in B. Scale bar: 40 µm
compared intensities of the specific PCR products. This quantitation
showed that HaCaT and suction blister specimens contained 1:32
and 1:16, respectively, the amounts of the bikunin specific transcript
in liver cells (data not shown). The presence of mRNA specific
for bikunin in epidermal keratinocytes and HaCaT cells was also
proved by northern blot analysis. The PCR sample amplified using
bikunin-specific primers from single-stranded cDNA derived from
human normal keratinocytes were subcloned to pCRScript vector
(Stratagene, La Jolla, CA) and sequenced by using either T7 or T3
primers and consequently the sequences were ascertained as 100%
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Figure 5. Bikunin is located on the cell membrane close to the
desmosomes of spinous cells. Normal human forearm skin was fixed
in 4% paraformaldehyde and reacted with anti-bikunin antibody. Arrows
indicate desmosomes. Gold particles were seen on the cell membrane close
to the desmosomes. N, nucleus. Scale bar: 0.5 µm.
Figure 6. mRNA of bikunin is expressed in human normal
keratinocytes and a keratinocyte cell line. RNA samples derived from
the keratinocyte cell line HaCaT (lane 1), samples of suction blister
specimens (lane 2) and cultured human normal keratinocytes (lane 3) were
reverse transcribed, and amplified with primers specific for either bikunin
(upper) or β-actin (bottom). As a positive control, cDNA derived from
human liver (lane 4) (Clontech, Palo Alto, CA) was used. Amplification
was performed in a semiquantitative way as described in Materials and
Methods. The respective PCR products were run on 3% agarose gels, and
specific fragments were visualized under an ultraviolet lamp. The
experiment was repeated three times and the data shown are from a
representative experiment.
identical to those of bikunin cDNA as listed in GenBank (data not
shown). RNA samples derived from human normal keratinocytes
and suction blister specimens, respectively, were run on 1% denatur-
ing agarose gels, blotted to nylon filters, and northern blot analysis
was performed using cDNA probe encoding bikunin labeled with
[32P]dATPα. As shown in Fig 7, both HaCaT cells and epidermis
derived from suction blister samples expressed detectable amounts
of signals specific for bikunin mRNA. The amount of expression
is higher in suction blister specimen HaCaT cells. This confirms
the reverse transcription–PCR data shown in Fig 6. These data
clearly demonstrate that keratinocytes express bikunin-specific
mRNA.
Figure 7. Human normal keratinocytes and the HaCaT cells express
significant amounts of bikunin transcript. RNA samples extracted
from human normal keratinocytes obtained from suction blister epidermis
(HNK) and the cells of spontaneously transformed human keratinocyte
cell line, HaCaT were run on 1% denaturing agarose gel, blotted on to
nylon membranes, and northern blot analysis performed using the cDNA
probe encoding bikunin. HNK expressed significant amounts of bikunin
transcripts (lane 2). HaCaT cells also expressed detectable amounts of
mRNA specific for bikunin (lane 1). Bikunin specific mRNA in HNK is
expressed approximately twice as much as those in HaCaT cells, confirming
the reverse transcription–PCR data.
DISCUSSION
The specificity of the anti-bikunin antibody was confirmed by
immunoblot analysis, as this antibody reacted with purified bikunin
and also with human serum inter-α-trypsin inhibitor and pre-α-
inhibitor, as shown in Fig 1(A). This specificity is the same as the
specificity of the anti-serum to bikunin reported by Itoh et al
(1996). In addition, both our anti-bikunin antibody and the anti-
serum to bikunin provided by Mochida Pharmaceutical Corp.
reacted with both the renal proximal tubules and the epidermis.
These results agree well with those reported by Yoshida et al (1989),
although the sample of anti-serum kindly given to us by Dr Yoshida
reacted in our hands with neither renal proximal tubular cells nor
epidermis. The titer of this anti-serum may have become drastically
reduced, as this anti-serum was produced more than 10 y ago, and
has been stored under poor conditions. In addition, the inhibitory
activity of bikunin (0.25 µg per ml) to trypsin was decreased from
33.1% to 6.0% by the addition of 1.68 µg of our anti-bikunin
antibody (data not shown). From the above results, we conclude
that our anti-bikunin antibody is specific for bikunin. The reason
why Yoshida et al failed to show a reaction in epidermis may be
that they used paraffin-embedded sections without any pretreat-
ment, and the titer of their anti-serum may not have been high
enough to detect the amount of bikunin in epidermis, which may
not be as high as the level in liver cells. In contrast, as we purified
our anti-serum through bikunin affinity column chromatography,
the titer of our antibody was very high.
As far as the origin of the bikunin in epidermis is concerned,
there are two possible mechanisms: one is a mechanism in which
the epidermal bikunin is derived from the serum and taken up by
keratinocytes by the same mechanism as that by which trypstatin
is incorporated into mast cells (Itoh et al, 1994). The other is a
mechanism in which bikunin is synthesized in the epidermal cells
and once secreted into extracellular domain then becomes bound
to the receptor of the keratinocyte cell membrane through an
autocrine mechanism. With regard to the first mechanism, it is
difficult in this case to explain why bikunin could be found neither
on the CB facing the basement membrane nor on the CB of the
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stratum granulosum cells, and why bikunin was found on the CB
of squamous cell carcinomas (six of six cases), but not in basal
cell carcinomas (none of five), when various skin tumors were
immunohistochemically examined by our anti-bikunin antibody
(data not shown). Furthermore, as there are no cells other than
epidermal cells which could produce the mRNA of bikunin, the
possibility of contamination of bikunin mRNA in our semiquantit-
ative reverse transcription–PCR system could be neglected.
Although dermal capillary endothelial cells showed immunohisto-
chemically strong reaction with the anti-bikunin antibody, these
cells may have taken up bikunin of serum origin. In addition,
cDNA derived from human keratinocytes expressed bikunin-
specific mRNA, and the product of our reverse transcription–PCR
experiment was confirmed to be identical to the mRNA of bikunin
itself and not other nonspecifically amplified transcripts. In addition,
the presence of bikunin-specific mRNA in keratinocytes was also
confirmed by northern blot analysis. Therefore, it appears that the
bikunin on the cell boundary of epidermal cells may be produced by
the keratinocytes themselves. Considering the process of bikunin-
mRNA formation in liver cells (Salier et al, 1996), either the
mRNA or protein of α1-microglubulin should in this case be
detected in epidermal cells. As there is no antibody to α1-
microglobulin commercially available in Japan, however, the pres-
ence of α 1-microglobulin remains untested. The reasons that
previous investigators could not detect either bikunin protein or
mRNA in epidermis may have been that (i) the titer of Yoshida’s
antibody might have been too low, and (ii) the technique of reverse
transcription–PCR which Itoh et al (1996) used might not have
been semiquantitative, as the amount of bikunin-specific transcript
in keratinocytes was quite small as compared with the amount in
liver cells. The reason why 43 kDa, 36 kDa, and 19 kDa
polypeptides in the extract of suction blister epidermis reacted with
anti-bikunin antibody, is that both 36 kDa and 19 kDa polypeptides
are probably the degradation products, produced during extraction
for 1 h at room temperature, as only a single 43 kDa protein was
detected when the epidermal cell lysate was subjected to SDS–
polyacrylamide gel electrophoresis immediately after homogeniza-
tion and transferred to Immobilon membranes for immunoblot
analysis.
As far as protease inhibitors in the epidermis are concerned,
three serine protease inhibitors have been reported in the human
epidermis. One is elafin, which is present in the upper spinous cell
layers of psoriatic skin, but not in normal skin (Wiedow et al, 1990;
Molhuizen et al, 1993). Another is the anti-leukoprotease which
was found in the secretions of mucosa and desquamation of psoriatic
skin (Seemuller et al, 1986; Boudier and Bieth, 1992; Wiedow
et al, 1993). Finally, PAI-2, which is an inhibitor of plasminogen
activator, was found in keratinocyte culture medium and at the
cell periphery of normal epidermis (Hibino et al, 1988; Hashimoto
et al, 1989; Lyons-Giordano et al, 1994; Schaefer et al, 1996), and
was shown to have an inhibitory effect on the acantholysis of
epidermis by pemphigus vulgaris auto-antibody in an organ culture
system, indicating that it may play an important part in blister
formation of pemphigus vulgaris through plasminogen activator
(Hashimoto et al, 1989). In this study we demonstrated that bikunin
was constantly present in normal human epidermis and was different
from the inhibitors elafin, anti-leukoprotease, and PAI-2
described above.
The physiologic function and the target protease of bikunin in
the epidermis remain unknown at present. The major adhesion
structure of keratinocytes, the desmosome, physiologically dissoci-
ates during cell division of keratinocytes in epidermis (Wolf and
Wolf-Schreiner, 1976; Koch et al, 1990; Buxton et al, 1993), and
the mechanism of this desmosomal dissociation during cell division
remains unknown. It may be the role of bikunin to regulate
dissociation of desmosomes of keratinocytes during cell division by
inhibition of protease activity. On the other hand, bikunin which
is also named ulinastatin (Miracrid), has been used for the treatment
of acute pancreatitis. Therefore, bikunin may play a part by linking
with its specific receptor on the cell surface (Kobayashi et al, 1994c)
in local regulation of exocrine enzymes and/or protection of
keratinocytes from proteases which are activated during inflam-
mation.
This study was partly supported by ‘‘JSID international scholarship, Kao Award’’
from the Japanese Society for Investigative Dermatology
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